• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
ZHANG Yan-yan, YOU Qi-dong. Application of dynamic resolution technology in the preparation of chiral drugs and chiral compounds[J]. Journal of China Pharmaceutical University, 2011, 42(1): 1-8.
Citation: ZHANG Yan-yan, YOU Qi-dong. Application of dynamic resolution technology in the preparation of chiral drugs and chiral compounds[J]. Journal of China Pharmaceutical University, 2011, 42(1): 1-8.

Application of dynamic resolution technology in the preparation of chiral drugs and chiral compounds

More Information
  • Dynamic resolution technology is one of the main approaches to obtain the single chiral compounds and has attracted much research interest.Dynamic resolution technology combines the resolution with racemization in situ.The key feature of this technology is the rapid racemization in situ of the unreactive enantiomer in the resolution of the racemic substrates.In this way,all the substrates could be converted into a single product isomer with a 100% theoretical yield.Generally speaking,in order to achieve high efficiency,the key point is to find the appropriate recemization conditions which are compatible with the resolution conditions.The dynamic resolution technology including dynamic kinetic resolution and dynamic thermodynamic resolution is summarized in this review and the latest research progress as well as the application in preparation of chiral drugs and chiral compounds are also presented.
  • Related Articles

    [1]XIA Ying, LONG Jiayi, DAI Haoran, SHEN Mengyuan, GUO Hongli, HU Yahui, CHEN Feng. Determination of digoxin in human plasma by LC-MS/MS and its application in pediatric patients[J]. Journal of China Pharmaceutical University, 2021, 52(6): 719-724. DOI: 10.11665/j.issn.1000-5048.20210610
    [2]XIA Ying, GUO Hongli, HU Yahui, CHEN Feng. Therapeutic drug monitoring for monoclonal antibody:progress in the application of LC-MS/MS technique[J]. Journal of China Pharmaceutical University, 2021, 52(1): 122-128. DOI: 10.11665/j.issn.1000-5048.20210117
    [3]LIANG Feng, LI Duo, WANG Rongbin, SHU Chang, DING Li. Pharmacokinetics and absolute bioavailability of isoschaftoside in rat by LC-MS/MS[J]. Journal of China Pharmaceutical University, 2019, 50(1): 75-80. DOI: 10.11665/j.issn.1000-5048.20190110
    [4]MU Yanan, YANG Jin. Determination of epothilone B in human blood by LC-MS/MS and its application in phase I pharmacokinetics study[J]. Journal of China Pharmaceutical University, 2013, 44(1): 89-92. DOI: 10.11665/j.issn.1000-5048.20130115
    [5]ZHANG Lu, QIANG Shuping, ZHANG Yunjing, WANG Lei, ZHANG Xiaofei, HANG Taijun. Preliminary identification of the related substances in cisatracurium besylate for injection by LC-MS[J]. Journal of China Pharmaceutical University, 2013, 44(1): 65-72. DOI: 10.11665/j.issn.1000-5048.20130111
    [6]KONG Xing-xin, SHEN Wen-bin, WANG Li-yun, SHI Jin-fang, DI Bin, ZHANG Tao. Identification of the related substances in cefmetazole sodium by LC-MS/MS[J]. Journal of China Pharmaceutical University, 2012, 43(2): 170-176.
    [7]QIN Fang, DING Ya, HANG Tai-jun, SONG Min. Identification of the related substances in faropenem sodium by LC-MS/MS[J]. Journal of China Pharmaceutical University, 2011, 42(4): 342-347.
    [8]SI Qian, CHEN Yuan-cheng, HUANG Li-hua, CHENG Yu, HE Hua, LIU Xiao-quan. Determination of nebivolol in human plasma by LC-MS/MS and study of its pharmacokinetics on the Chinese[J]. Journal of China Pharmaceutical University, 2011, 42(2): 136-140.
    [9]TIAN Yuan, FENG Shu-dan, HUANG Mei-hua, ZHANG Zun-jian. LC-MS/MS determination of glucocorticoids illegally added into cosmetics[J]. Journal of China Pharmaceutical University, 2011, 42(1): 53-57.
    [10]Multiresidue determination of fluoroquinolones in eggs by solid-phase extraction-LC-MS/MS[J]. Journal of China Pharmaceutical University, 2010, 41(1): 60-65.

Catalog

    Article views (3862) PDF downloads (5337) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return